Frohlich Tom
- SEC CIK
- 0001823925
No open-market purchases or sales filed in the past year.
Current role at each company
- JBIO Jade Biosciences, Inc.Chief Executive Officeras of Feb 13, 2026
- KDNY Chinook Therapeutics, Inc.Chief Operating Officeras of Aug 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Frohlich Tom as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JBIO Jade Biosciences, Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 (view filing) | May 16 | 3 days | Frohlich TomChief Executive Officer | PPurchase | +6.00K | $7.40 | +$44.4K | New position6.00K after |
KDNY Chinook Therapeutics, Inc.
Chief Operating Officer9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 (view filing) | Feb 10 | 5 daysLate | Frohlich TomChief Operating Officer | SSale | −3.70K | $23.75 | −$87.9K | −2.4%150.8K after | |
| Feb 2, 2023 (view filing) | Jan 31 | 2 days | Frohlich TomChief Operating Officer | SSale | −4.57K | $24.68 | −$112.7K | −3.0%147.7K after | |
| Dec 15, 2022 (view filing)4:28 PM ET | Dec 13 | 2 days | Frohlich TomChief Operating Officer | SSale | −10.0K | $25.00 | −$250.0K | −6.5%143.9K after | |
| Nov 9, 2022 (view filing)4:21 PM ET | Nov 7 | 2 days | Frohlich TomChief Operating Officer | SSale | −10.0K | $22.16 | −$221.6K | −6.5%143.9K after | |
| Oct 11, 2022 (view filing) | Oct 6 | 5 days | Frohlich TomChief Operating Officer | SSale | −7.36K | $19.69 | −$144.9K | −4.9%143.9K after | |
| Feb 14, 2022 (view filing) | Feb 11 | 3 days | Frohlich TomChief Operating Officer | SSale | −3.73K | $12.74 | −$47.6K | −2.6%137.7K after | |
| Nov 12, 2021 (view filing) | Nov 10 | 2 days | Frohlich TomChief Operating Officer | SSale | −6.23K | $15.48 | −$96.4K | −4.4%134.6K after | |
| Nov 9, 2021 (view filing)9:40 PM ET | Nov 5-8 | 4 days | Frohlich TomChief Operating Officer | SSale | −33.8K | $14.48 | −$488.9K | −19.3%140.8K after | 3 lots |
| Sep 24, 2021 (view filing) | Sep 24 | Same day | Frohlich TomChief Operating Officer | SSale | −20.0K | $13.00 | −$260.0K | −13.0%133.4K after |